HB 5682 redirects $72 million in unused funds from previous fiscal years to support biomedical research at West Virginia medical schools. It expires $37 million from the 2023 Governor’s Civil Contingent Fund and $35 million from the 2017 fund, adding these to the General Revenue surplus for the 2026 fiscal year. The funds are specifically allocated to: $30 million for Marshall University School of Medicine, $5 million for West Virginia University Dental School, $32 million for West Virginia University School of Medicine, and $5 million for the West Virginia School of Osteopathic Medicine. This supplemental appropriation expands biomedical research capacity without creating new taxes or spending.
HB 5022 expands the annual review of healthcare reimbursement rates to include additional programs beyond the current four (Intellectual and Developmental Disabilities Waiver, Aged and Disabled Waiver, Personal Care Services, and Traumatic Brain Injury Waiver). The bill requires the Bureau for Medical Services to annually study provider costs - including inflation, staffing expenses, and contract changes - and compare rates with similar programs in other states. Providers must submit financial data to support these reviews, and the bureau must report findings and rate adjustment recommendations to the Joint Committee on Finance each year. This change directly affects healthcare providers serving Medicaid waiver program participants in West Virginia.
HB 5430 regulates pharmacy benefit managers (PBMs) for West Virginia's Public Employees Insurance Agency (PEIA), directly affecting state employees covered by PEIA, PBMs, and pharmacies providing services to them. The bill requires PBMs to submit detailed quarterly reports on claim payments, including costs charged to PEIA versus amounts paid to pharmacies, and prohibits certain PBM contracts that limit transparency. It also mandates PBMs to implement a cost containment tool and requires a study on pharmacy pricing. The law aims to increase transparency in pharmacy billing and control costs for state health insurance programs.
HB 5327, the West Virginia ALS Care Services Act, establishes a state program to provide targeted support for residents living with ALS and their caregivers. The bill requires the Department of Human Services to fund three key services: care coordination and education to help navigate healthcare systems, loan programs for assistive technology and reusable ramps (addressing a common financial barrier as ramps aren't typically covered by insurance), and access to multidisciplinary ALS clinics. These clinics consolidate specialized care, reduce the need for repeated specialist visits and emergency care, and aim to improve patient outcomes while lowering long-term healthcare costs. The program directly affects West Virginia ALS patients and their families by enabling them to remain safely at home longer, reducing reliance on costly institutional care.
HB 5458 creates a new Genetic Counselors Practice Act under West Virginia law, directly affecting individuals seeking to practice genetic counseling in the state. The bill requires criminal background checks for all new genetic counseling license applicants, mandates that practitioners hold a valid license before providing services, and defines the scope of genetic counseling practice. It prohibits genetic counselors from representing themselves as licensed physicians and establishes penalties including up to two years in prison or a $2,000 fine for violations. The bill also sets continuing education requirements, licensure renewal processes, and disciplinary procedures specific to genetic counselors.
HB 5459 imposes an annual tax on certified health maintenance organizations (HMOs) operating in West Virginia that provide Medicaid services. It establishes tiered tax rates based on Medicaid member months (with higher rates for larger volumes) and non-Medicaid member months, adjusting annually using West Virginia's Medicaid capitation rate changes. Starting July 1, 2027, the tax shifts to a flat 2.5% of each HMO's gross premiums in the state, applying uniformly regardless of membership type. The bill exempts Medicare Advantage plans and certain government health plans as specified in federal law.
HB 4474 extends the expiration date of West Virginia's Alzheimer's Disease and Other Dementia Advisory Council, which was scheduled to sunset. The bill prevents the council from automatically dissolving by renewing its operational period. The council, composed of 15 voting members (including people with dementia, caregivers, healthcare providers, and researchers) and 5 nonvoting government representatives, examines dementia care needs, reviews state services, and assesses healthcare capacity. It does not create new policies but ensures the council can continue its work on dementia-related issues. This procedural bill affects only the council's continued operation, not direct service recipients.
HB 4819 would change West Virginia's licensing rules for professions requiring state authorization. It prevents disqualification for most past criminal convictions unless the crime directly relates to the profession's duties and poses a clear public risk. Licensing agencies must now consider factors like the crime's nature, time passed since conviction, and evidence of rehabilitation (such as completed treatment or employment history) before denying a license. Applicants with past convictions can petition for reconsideration after five years without new offenses (excluding violent/sexual crimes), with agencies required to respond within 60 days. This affects all individuals seeking professional licenses in West Virginia, including fields like healthcare, education, or licensed trades.
HB 4335 requires West Virginia's Medicaid program to process provider enrollment applications within 5 business days of receipt and mandates managed care organizations to complete provider credentialing within 60 days. The bill establishes a unified electronic platform for all Medicaid provider applications, renewals, and documentation, eliminating paper submissions starting July 1, 2026. It also sets penalties for managed care organizations that miss deadlines, including monetary sanctions or "credentialing-by-default" by the Department of Human Services. This bill directly affects Medicaid providers (like doctors and clinics), managed care organizations, and the Department of Human Services.
HB 4196 requires licensed medication-assisted treatment (MAT) programs in West Virginia to offer long-acting reversible contraception (LARC), such as IUDs or implants, to patients receiving methadone or suboxone for substance use treatment. This applies to all facilities providing these services under the state's licensing framework, adding it as a standard requirement to existing operational rules. The bill directly affects MAT facilities, which must now integrate LARC options into their care protocols, and patients using methadone or suboxone at these locations. It creates a concrete policy change by mandating access to these contraceptive methods without requiring additional patient steps.
